Table 1.

US Food and Drug Administration–Approved Gadolinium-Based Contrast Agents^14-18

Generic Name	Brand Name	Date Approved	Chemical Structure	Indication
Gadopentetate dimeglumine	Magnevist	6/2/1988	Linear	Central nervous system, extracranial/extraspinal, body
Gadoteridol	ProHance	11/16/1992	Macrocyclic	Central nervous system, extracranial/extraspinal
Gadoversetamide	OptiMARK	12/8/1999	Linear	Central nervous system, liver
Gadobenate dimeglumine	MultiHance	11/23/2004	Linear	Central nervous system, renal or aortoiliofemoral occlusive vascular disease
Gadodiamide	Omniscan	9/5/2007	Linear	Central nervous system, body
Gadoxetate disodium	Eovist	7/3/2008	Linear	Liver lesions
Gadofosveset trisodium	Ablavar (formerly Vasovist)	12/22/2008	Linear	Aortoiliac occlusive disease
Gadobutrol	Gadavist	3/14/2011	Macrocyclic	Central nervous system
Gadoterate meglumine	Dotarem	3/20/2013	Macrocyclic	Central nervous system